PURPOSE: The clinical features and prognosis of mucinous breast carcinoma (MBC) are unclear because of its rarity. The aim was to describe the clinicopathological features and prognosis of patients with MBC in comparison with nonmucinous breast carcinoma (NMBC). Furthermore, we described the biological behavior of pure mucinous breast carcinoma (PMBC) by comparing clinicopathological features and prognosis with mixed mucinous breast carcinoma (MMBC). METHODS: We reviewed the records of 5,872 consecutive patients diagnosed with breast carcinoma who were resected surgically from March 2003 to October 2010. Among them, 117 patients with MBC were compared to 5,575 patients with NMBC. Furthermore, 88 patients with PMBC were compared to 29 patients with MMBC. RESULTS: There were statistical differences in age, pN stage, ER level, and PR level between the patients with MBC and NMBC. There were statistical differences in pT stage and pN stage between the patients with PMBC and MMBC. The overall five-year survival of patients with MBC was 88.1 % as compared with 81.9 % for patients with NMBC. The overall five-year survival of patients with PMBC was 91.3 % as compared with 80.4 % for patients with MMBC. The overall five-year survival of patients with PMBC was 91.3 % as compared with 81.9 % for patients with NMBC. CONCLUSIONS: PMBC tended to have a better prognosis in comparison with other types of breast carcinoma.
PURPOSE: The clinical features and prognosis of mucinous breast carcinoma (MBC) are unclear because of its rarity. The aim was to describe the clinicopathological features and prognosis of patients with MBC in comparison with nonmucinous breast carcinoma (NMBC). Furthermore, we described the biological behavior of pure mucinous breast carcinoma (PMBC) by comparing clinicopathological features and prognosis with mixed mucinous breast carcinoma (MMBC). METHODS: We reviewed the records of 5,872 consecutive patients diagnosed with breast carcinoma who were resected surgically from March 2003 to October 2010. Among them, 117 patients with MBC were compared to 5,575 patients with NMBC. Furthermore, 88 patients with PMBC were compared to 29 patients with MMBC. RESULTS: There were statistical differences in age, pN stage, ER level, and PR level between the patients with MBC and NMBC. There were statistical differences in pT stage and pN stage between the patients with PMBC and MMBC. The overall five-year survival of patients with MBC was 88.1 % as compared with 81.9 % for patients with NMBC. The overall five-year survival of patients with PMBC was 91.3 % as compared with 80.4 % for patients with MMBC. The overall five-year survival of patients with PMBC was 91.3 % as compared with 81.9 % for patients with NMBC. CONCLUSIONS:PMBC tended to have a better prognosis in comparison with other types of breast carcinoma.
Authors: Christina R Barkley; Jennifer A Ligibel; Julia S Wong; Stuart Lipsitz; Barbara L Smith; Mehra Golshan Journal: Am J Surg Date: 2008-10 Impact factor: 2.565
Authors: Juan C Paramo; Christopher Wilson; Diego Velarde; Jaime Giraldo; Robert J Poppiti; Thomas W Mesko Journal: Ann Surg Oncol Date: 2002-03 Impact factor: 5.344
Authors: Ian K Komenaka; Mahmoud B El-Tamer; Andrea Troxel; Diane Hamele-Bena; Kathie-Ann Joseph; Elizabeth Horowitz; Beth-Ann Ditkoff; Freya R Schnabel Journal: Am J Surg Date: 2004-04 Impact factor: 2.565
Authors: Niek Hugen; Michiel Simons; Altuna Halilović; Rachel S van der Post; Anna J Bogers; Monica Aj Marijnissen-van Zanten; Johannes Hw de Wilt; Iris D Nagtegaal Journal: J Pathol Clin Res Date: 2014-11-05
Authors: Xiufeng Wu; Zhenzhen Zhang; Xin Li; Qingzhong Lin; Gang Chen; Jianping Lu; Yi Zeng; Dan Hu; Kai Huang; Zhiwu Lin; Jun Yan Journal: PLoS One Date: 2016-09-01 Impact factor: 3.240
Authors: Hyung Suk Kim; Jong Uk Lee; Tae Kyung Yoo; Byung Joo Chae; Donghee Son; Yun Jin Kim; Woo Chan Park Journal: J Breast Cancer Date: 2019-09-30 Impact factor: 3.588